Corporate Governance

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment


The company’s auditor is appointed by the Annual General Meeting (AGM) for the period until the end of the next AGM. At the Annual General Meeting 2021, until the end of the 2022 AGM, the registered auditing firm BDO Mälardalen AB was re-elected as auditor.

Karin Siwertz is the auditor in charge.

The auditor reviews the accounts of the parent company and the group on behalf of the AGM. The external auditing of the parent company and the group’s accounts, as well as of the Board and CEO’s management, are conducted in accordance with generally accepted auditing standards in Sweden.

The auditor can be reached via BDO Mälardalen AB, Turebergs Allé 2, 191 62 Sollentuna.



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10